Integration of mechanism-based in vitro methods and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for prediction of nephrotoxicity

被引:0
|
作者
Mally, A. [1 ]
Birk, B. [2 ]
DiFiore, S. [3 ]
Ellinger, B. [4 ]
Jarzina, S. [1 ]
Taverne, F. [5 ]
Kramer, N. [5 ]
机构
[1] Univ Wurzburg, Dept Toxicol, Wurzburg, Germany
[2] BASF, Expt Toxicol & Ecol, Ludwigshafen, Germany
[3] Fraunhofer Inst Mol Biol & Appl Ecol, Div Mol Biotechnol, Aachen, Germany
[4] Fraunhofer Inst Mol Biol & Appl Ecol, Div Translat Med, Hamburg, Germany
[5] Univ Utrecht, Inst Risk Assessment Sci, Toxicol Div, Utrecht, Netherlands
关键词
D O I
10.1016/j.toxlet.2018.06.1123
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
S08-02
引用
收藏
页码:S27 / S27
页数:1
相关论文
共 50 条
  • [31] Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs
    Poulin, Patrick
    Hop, Cornelis E. C. A.
    Ho, Quynh
    Halladay, Jason S.
    Haddad, Sami
    Kenny, Jane R.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (11) : 4308 - 4326
  • [32] IN VITRO-IN VIVO EXTRAPOLATION FOR DRUGS' PRO-ARRHYTHMIC POTENCY ASSESSMENT WITH USE OF MODELLING AND SIMULATION APPROACH
    Polak, Sebastian
    DRUG METABOLISM REVIEWS, 2015, 47 : 26 - 27
  • [33] Bioconcentration Assessment in Fish Based on In Vitro Intrinsic Clearance: Predictivity of an Empirical Model Compared to In Vitro-In Vivo Extrapolation Models
    Laue, Heike
    Hostettler, Lu
    Jenner, Karen J.
    Sanders, Gordon
    Natsch, Andreas
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2023, 57 (36) : 13325 - 13335
  • [34] Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation
    Liu, Zhihao
    Liu, Kexin
    CURRENT DRUG METABOLISM, 2016, 17 (05) : 456 - 468
  • [35] PBTK modeling of potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico-in vitro based risk assessments
    Fabian, E.
    Haase, C.
    Ramirez, T.
    Gomes, C.
    Birk, B.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S79 - S79
  • [36] PBTK modeling of selected potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico/in vitro based risk assessments
    Haase, C.
    Fabian, E.
    Ramirez, T.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S47 - S47
  • [37] Validation of Methods for in Vitro-in Vivo Extrapolation Using Hepatic Clearance Measurements in Isolated Perfused Fish Livers
    Schultz, Matthew
    Krause, Sophia
    Brinkmann, Markus
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2022, 56 (17) : 12416 - 12423
  • [38] In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods
    Yoshida, Kenta
    Zhao, Ping
    Zhang, Lei
    Abernethy, Darrell R.
    Rekic, Dinko
    Reynolds, Kellie S.
    Galetin, Aleksandra
    Huang, Shiew-Mei
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2209 - 2213
  • [39] Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation
    Izat, Nihan
    Bolleddula, Jayaprakasam
    Abbasi, Armina
    Cheruzel, Lionel
    Jones, Robert S.
    Moss, Darren
    Ortega-Muro, Fatima
    Parmentier, Yannick
    Peterkin, Vincent C.
    Tian, Dan-Dan
    Venkatakrishnan, Karthik
    Zientek, Michael A.
    Barber, Jill
    Houston, J. Brian
    Galetin, Aleksandra
    Scotcher, Daniel
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (12) : 1591 - 1606
  • [40] A critical evaluation of the experimental design used in reports of mechanism based inhibition (MBI) studies and the assessment of their implication for in vitro-in vivo extrapolation
    Ghanbari, F
    Yeo, KR
    Lennard, MS
    Tucker, GT
    Rostami-Hodjegan, A
    DRUG METABOLISM REVIEWS, 2005, 37 : 69 - 70